Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Bag,
No, that's not it. It has been too quiet since the Tampa articles and the bleeding has stopped of shares. It's too early and not immediately necessary for reduction of Authorized shares. It's something else. And it really smells like change in corporate structure to enable some kind of arrangement with another company, someone bigger. That is what I got from the 10k.(JMO)
This selloff sucks, yes, and the shorts are real happy. But also notice the names that are showing up here. Look closely.
The reason this is disconcerting is that we have seen it so many times before, and who likes to get goosed forever?
But there is the fact that the longer this company is in business, the harder it is to pull down, and 7 years is not your typical penny loser.
Good luck. I am staying in and until Gomez quits, I won't lose any sleep. The sp is going down. And alot of the short termers we saw show up looking for a quick buck are bailing and the buzzards are on the fence post.
If there is a restructuring that includes shares revision, you can be sure it includes some real gorillas backing it up. That's all I can say here.
The best to you, Bag.
Frogster,
I have seen you say idiotic things before, but that was beyond all coprehension. Good luck to you in your world Frogdreaming.
"Remember that 'value' is always defiend by the buyer."
Not necessarily. First the owner has to want to sell. And then a "value" is defined by how much the final agreed price is.
If there is a final price.
Hence sharestructure. Using the lack of a Merck buyout as some kind of reason to say that DNAPrint isn't worth it is
ignorant and shortsighted.
A lack of a buyout could actually mean the opposite. It could mean that DNAPrint values it's future enough to go out of the way to mmake sure it keeps 60 % of it's O.S. out of the hands of others. At any cost.
Bashing on supposition. Pumping on supposition.
What a zoo.
Stockchild,
I think you are right!~ Does that advice come from personal experience?
Excuse me, that's "spammmmmmmmm". eom
1. Yes, but mostly to people who span on their very first post.
2. I'm sure she did. You're english is good.
3. Do you know anything about this company? What does M2Gen mean?
Stockchild..
Go take a downer, it'll bring you up.
And Froggie,
Don't mistake disgust as anger.
There are other reasons the Indian PHD's (not "all" the staff) were let go. You also "failed" to mention the theft of company property by one of them.
The Gabriel move was a good one. Period.
Your "outsourcing" argument is ridiculous. Are you saying that better technology should be thrown in the dumpster?
Let's hear your opinion of Shriver. Are you better than him too?
And what about the trash you put out on buying losing companies?
Let's hear your thoughts on Ellipsis and Trace.
On second thought, forget it. You use half truths and partial reality to push your agenda.
Grind the axe, Froggie, grind the axe.
Froggie,
You are a liar. Period.
Now you have changed your words.
Now the word "all" has changed to a few instances that happen in EVERY business. You can't get away with this one, so don't even try.
Just tell us why you are really here.
And if you want to call typical business procedure "outsourcing" then just make sure you never own your own business. You would fail instantly.
You are not worth the time.
You are a deceptionist anmd an evader.
Mr Smart Guy. Put you on the witness stand and you would shrivel like a raisin.
And get over the bold type.
Go do something that doesn't waste our time.
Johnnyfiber;
Note; Your post on the expenses of the new lab are dated last April. It will be interesting to compare those figures with the next quarterly statement, (if they state those expendiatures)and see if the equipment outlay has increased. The former doesn't seem like much. If we get projected numbers for 2007 it may show intention of larger volume of work.
BTW, 6k a month for rent isn't too bad.
This morning on the Today show a totally white Texan man with cowboy hat and all came on the show with his newly found close relative by DNA, a black woman.
Both very involved in philanthropic causes in theiir respective cities and how their families now met, totally white and totally black. They both told their percentage of native, european, and caucasian, obviously a AncestrybyDNA test.
No mention of DNAPrint, of course, but Matt Lauer was excited, whatever that means.
Just biding the time.........
wrl..
Even Luca Brasi didn't squeal like one of these chicken-snit bashers. Did you like Fartdinkle's story about someone threatening him? W E A K.
Frogster,
What a dirty little liar you are. DNAPrint did not lay off "all" their in house scientific staff. They did NOT replace their existing management, (were YOU the one they fired?) they have NOT "outsourced" their science, (unless you want to talk about the 2 companies we bought which now make a profit; Ellipsis & Trace) and you don't "push back" milestones for projects. The fact is, we DO have milestones for our priojects.
"Extracting Profit from investors?" Trash talk from a punk know-it-all. Non-sensical and spewing saliva is about all that adds up to.
"They use science for a facade for their activities> Sounds alot like YOU, Froggie! Maybe you shopuld tell that to MOffitt, or Beth Deaconess, Or Penn state University, or even the detectives in Louisianna.
"They trade shares for dying companies". Uh, yeah, right. That is why Ellipsis is making a profit one year after we bought it. What an axe-grinding moron you are.
You aren't a shareholder in this company. For a guy who acts so smart, you sure pick moments to lose all logical and pragmatic sensibility and basically look and sound like an idiot.
What is it Froggie? Did you get fired by DNAP? Did you work for the same company in Seattle as Frudakis and he left you in the dust? Or are you just a paid hit man with a little knowledge of genomics but with zero class?
I think it is that Frudakis left you in the dust. He is right where you one day wanted to be.
You call this company a loser, yet you act so much smarter than everyone here and yet try to say you were stupid enough to buy the stock?
Bullshi--.
Just another loser. How does it feel??
That was the stupidist thing I've heard all day.
Just because Johnny's brick supply has 100 times more bricks than Larry's doesn't mean Johnny can build a better brick house.
A friend I grew up with now works in Saudi Arabia for IBM(SBM)selling software to OPEC members. We have had the discussion about IBM's Life Sciences and computational capabilities,(including their latest computational advances) and DNAPrint's
platforms and projects. Long story short, he purchased his first shares of DNAG 3 years ago and has doubled his holdings three times, the last time being Ellipsis showed profit.
Frogdreaming, your statement goes a long way to prove you don't know what the hell you are talking about. AT ALL.
And when the company proves little froggie wrong then he will disappear into the night. Simple.
He will never be able to deal with the fact that Dr Frudakis is superior to him in all respects. Simple.
On another subject of importance, there has been mention as to the purpose of the sale of Biofrontera stock. All speculation aside, we need discussion on the cost of building the new lab,(how mwny 1000's of feet?) and equipment. This could also lend credence to the argument that DNAPrint is involved in the M2Gen
project.
The equipment, lease, security, computational capacities, storage and personell surely add up to millions and would have to be ready to go ASAP.
Just some thing to munch on....
Investors often forget about the logistics and expenses involved in the 'machinery' of their companies.
Waveaura,
This thread was originally established for posters to discuss DNAPrint, not just for traders or short-term greedy fools. The discussion on Epofusion is important, as anyone who has a long term interest in this company sees that this modeling can save any pharmaceutical company tens of millions of dollars. That is a product.
The poster Frogdreaming has consistently bashed this company for reasons unclear and it is important to call him out on every single point he uses to downplay DNAPrint's viability. He has obviously worked in the bio industry for years but has a serious axe to grind with DNAPrint, which is unfortunate, as the knowledge is valuable yet used in a deceptive manner.
Be patient.
Frog,
I won't even dignify that accusation with an answer. Your insinuations once again ruin what could be reasonable discourse. If you think about the time involved to set up such a deal and that the monies don't come all at once, your conspiracy theory just takes us back to your axe grinding.
You see evil wherever you can bake it up.
Once again, a waste of time.
Don't bother replying.
For the same reason that there is no information out there from any of the companies who are involved, including Merck, except what has been given in the original press releases which amount to like, two.
Nothing from Merck, nothing from GE Health, nothing from Moffitt, nothing, nothing, nothing.
Maybe, just maybe, some people know how to keep things quiet.
Frog,
The obvious reason for the prompt sale of Biofrontera holdings is that DNAPrint needs the cash and needs to stop the bleeding of shares thereby reducing the odds of a share restructure down the road. It is a critical time as the company must make sure control is kept in their hands. Anything that works towards selling fewer shares is paramount.
It also means that although revenues could be higher right now, they are still at least 9 months off from seeing the kind of control needed. Salaries and taxes alone are at least 120k per month and the new lab expense in setup will be huge.
Borrowing against the BftAG shares just doesn't make sense and it could very possibly be that release of the shares under that suituation wouldn't happen. Biofrontera will be licensing it's latest discovery and obviously is also looking at a big improvement by year end. So if DNAPrint has the right to buy back in at $18.00(16.00)euro) and D.AG. stock is at what, $23.00 for instance, then what?.
The only thing that the sale of Biofrontera stock tells me is that both companies are looking at much more revenue later in the year and that DNAPrint puts off the worry of share restructure. Damn, I hate losing a good asset, yet the option to buy back in is just that; an option and/or opportunity.
The difference is I admit it. You don't.
lizm67,
It is just my opinion and nothing more, but I believe that when our research at Moffitt began quite awhile ago, Gomez already had been in close contact with Merck and that Merck said go ahead and do the research and keep us informed.
With a close eye on results that were obviously productive, Merck began to see thru Gomez, Moffitt and DnaPrint a direction for the future. All of the big Pharms face the same challenges; expiration of patents and generics; multiple lawsuits, and their own little share of over 160,000 people killed every year by reactions to pharmaceuticals, not to mention injuries and higher medical costs,; all of which now show promise of being reduced by using pharmacogenomics.
And now the FDA is taking the progressive road by demanding this kind of resaerch.
Top it off with DNAPrint's supposed ability to stream line drug certification and approval by computational methods saving possibly 100's of millions of dollars and precious time.
This is what I think is going on, and has been for awhile.
Some people say insider info would sneak out and we would see it in the ssp if it were true. I am not so sure of that.
Remember, Gomez already worked with Merck and they all know the importance high level discretion.
Yeah, frogster,
As usual we are all stupid and you are smarter than everyone else.
I don't care who Jonnyfiber is. But you surely do.
He is no worse or better than you. Which is something "Your Highness" will never get.
Whats-za-matter, don't you like hard-boiled froggie?
JF,
Is it like a lobster thing?
What kind of sound do you get when a live frog hits boiling water?
johnnyfiber,
I think you should seriously consider a name change to "webwizz"
Now there ya go; it just SEEMS longer. What would anticipation be without a little anxiety?
From Amber alert to Ancestry to police departments across the U.S., to Canada, to Australia, to Germany, to South Africa, to renowned Universities, to Cancer centers, to Chinese expeditions of 1420, to multiple diseases, to multiple drugs, and to your own doctor.
The painting is huge and you have to take several steps back to get the whole picture.
Watching water come to a boil at 20,000 feet is a bitchhhhhhhhhhh.
lizm67,
It appears that our croaking amphibians are facing population reduction worldwide due to environmental factors.
And all this time I thought the core reason for this disaster was due to a destructive disposition of negativity.
Sorry, Froggie, couldn't resist:
http://www.scienceinafrica.co.za/2002/april/frog.htm
JF,
I don't remember if all the shares were restricted, or even if they were fresh shares coming from Dutchess, but the trading yesterday showed big blocks towards the end of the day and it was odd. Put that at the first of the month it is either money being raised or shorts getting out. It's all speculation, but it had the feel to it as a Dutchess/Dnap move. Whatever.
BTW, maybe we should ask Froggie if he worked at Corixa with Tony. Corixa was near Seattle where the Frogster is and was bought out by GSK in '95. But it would make sense as he hates Frudakis to the bone and wants to see the company go down. Sounds like a little jealousy to me. Probably still stuck in his office/lab whimpering over what could have been. Maybe not......
Johnnyfiber,
That is why all the shares hit the market yesterday as soon as it turned March. Three days is very little padding.
goliath,
very nice. good move.
OOps! lol
"I am wrong quite often my dear, and every time I fess up to it."
I don't remember you ever admitting you were wrong. Must have slipped thru the invisable cracks.
"The 'fact' that there has been no reaction, is a bankable indicator. There is no relationship"
Prove it.
The 10QSB at March end is what to look for.
Prove it.
Frog,
But you still can't prove what you say, can you?
Gandolf,
Good luck to you also. I do not know if it would be called "unbridled enthusiasm", or just plain stubborness.
I have been part of many a fledgling business, and have learned to take a non-emotional and pragmatic approach to business plans and management decisions.
I see DNAPrint as a fledgling biotech inventing it's own path with cutting-edge technology in a environment that is not only heavily regulated but filled with 900 pound gorillas and a need for discretion at every move.
This company should not sell out to anybody. Instead it has bought two profitable businesses, and invested in one that has already become worth 10 million as share value.
A human child is how mature at 7 years old? DNAPrint must raise itself, and must build upon the proper foundation so that all the gears will move together. Maybe the suspense is worth the ride alone, at least for some of us.
Thanks for being a member of the board, and don't forget to check in once and a while.
Sorry; and that is on the assumption that Merck even has an association with DNAPrint.
Gandolf,
Please review the first news articles about M2Gen. I think there is mention of Merck keeping contracts and associations secret for now. It would only be typical taking into consideration competitive factors. Even though a Merck/DNAPrint association may be newsworthy and comforting to shareholders, it still only means revenues down the road, and DNAPrint has many other irons in the fire that equal or outweigh such an association.
If DNAPrint can save Pharms 100's of millions by cutting the time of drug-to-market, they will be in the driver's seat. Maybe this is why Merck wants associations kept quiet right now.